Search

Displaying results 6841 - 6850 of 10000 in total
  1. Drug

    Carafiban

    go.drugbank.com/drugs/DB19813
    Experimental

    Carafiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Carafiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). … Carafiban has a monoisotopic molecular weight of 465.2 Da.

  2. Drug

    Licostinel

    go.drugbank.com/drugs/DB19864
    Experimental

    Licostinel is a small molecule drug. The usage of the INN stem '-stinel' in the name indicates that Licostinel is a N-methyl-D-aspartate (NMDA) receptor co-agonist. … Licostinel has a monoisotopic molecular weight of 274.95 Da.

    Categories: Heterocyclic Compounds, 2-Ring
  3. Drug

    Orbofiban

    go.drugbank.com/drugs/DB20676
    Experimental

    Orbofiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Orbofiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). … Orbofiban has a monoisotopic molecular weight of 361.18 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Gantofiban

    go.drugbank.com/drugs/DB20951
    Experimental

    Gantofiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Gantofiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). … Gantofiban has a monoisotopic molecular weight of 447.21 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Roxifiban

    go.drugbank.com/drugs/DB21089
    Experimental

    Roxifiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Roxifiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). … Roxifiban has a monoisotopic molecular weight of 447.21 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  6. Drug

    Sibrafiban

    go.drugbank.com/drugs/DB21420
    Experimental

    Sibrafiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Sibrafiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). … Sibrafiban has a monoisotopic molecular weight of 420.2 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  7. Drug

    Padoprazan

    go.drugbank.com/drugs/DB21689
    Experimental

    Padoprazan is a small molecule drug. The usage of the INN stem '-prazan' in the name indicates that Padoprazan is a proton pump inhibitor, not dependent on acid activation. … Padoprazan has a monoisotopic molecular weight of 405.12 Da.

  8. Drug

    Zerencotrep

    go.drugbank.com/drugs/DB21710
    Experimental

    Zerencotrep is a small molecule drug. The usage of the INN stem '-cotrep' in the name indicates that Zerencotrep is a transient receptor potential canonical channel 5 (TRPC5) antagonist. … Zerencotrep has a monoisotopic molecular weight of 524.11 Da.

    Categories: Heterocyclic Compounds, 2-Ring
  9. Drug

    ZYCOV-D

    go.drugbank.com/drugs/DB15892
    Experimental

    Once the plasmid DNA is introduced into host cells and the viral protein is translated, it elicits a strong immune response, stimulating the humoral and cellular components of the immune system[L16503] … As of August, 2020 the candidate is in Phase II clinical trials[A219758].

  10. Drug

    OAV201

    go.drugbank.com/drugs/DB17842
    Experimental

    OAV201 is a non-replicating, recombinant adeno-associated virus serotype 9 (AAV9) containing the human Methyl CpG Binding Protein 2B (MECP2B) cDNA under the control of a segment of the murine MECP2 promoter … It was first developed by Novartis and investigated for the treatment of Rett syndrome, but further investigation in clinical trials was halted.[L46661]